Key facts
- This page summarizes Richard E. Lowenthal's Form 4 filing for ARS Pharmaceuticals, Inc. (SPRY).
- 6 reported transactions and 0 derivative rows are listed below.
- Filing timestamp: 21 Aug 2024, 18:47.
Richard E. Lowenthal - 20 Aug 2024 Form 4 Insider Report for ARS Pharmaceuticals, Inc. (SPRY)
- Signature
- /s/ Kathleen Scott, Attorney-in-Fact
- Issuer symbol
- SPRY
- Transaction date
- 20 Aug 2024
- Net transaction value
- -$1,502,587
- Form type
- 4
- Filing time
- 21 Aug 2024, 18:47:25 UTC
- Previous filing
- 15 Aug 2024
- Next filing
- 12 Sep 2024
- SEC filing
- View on sec.gov
Reporting owner
2 facts
Issuer context
1 fact
Transaction snapshot
2 facts
SEC evidence
5 facts
Key filing fact
Richard E. Lowenthal filed Form 4 for ARS Pharmaceuticals, Inc. (SPRY) on 21 Aug 2024.
Change
- Previous filing in this sequence was filed on 15 Aug 2024.
- Current net transaction value: -$1,502,587.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
See Original Filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported transactions
SPRY
transaction
Common Stock
Sale
- Transaction value
- $530,408
- Shares
- -35,944
- Change %
- -2.3%
- Price
- $14.76
- Shares after
- 1,511,503
- Date
- 20 Aug 2024
- Ownership
- By Sarina Tanimoto Charitable Remainder UniTrust Dated January 7, 2020
- Footnotes
- F1, F2, F3
SPRY
transaction
Common Stock
Sale
- Transaction value
- $183,545
- Shares
- -11,756
- Change %
- -0.78%
- Price
- $15.61
- Shares after
- 1,499,747
- Date
- 20 Aug 2024
- Ownership
- By Sarina Tanimoto Charitable Remainder UniTrust Dated January 7, 2020
- Footnotes
- F1, F3, F4
SPRY
transaction
Common Stock
Sale
- Transaction value
- $37,395
- Shares
- -2,300
- Change %
- -0.15%
- Price
- $16.26
- Shares after
- 1,497,447
- Date
- 20 Aug 2024
- Ownership
- By Sarina Tanimoto Charitable Remainder UniTrust Dated January 7, 2020
- Footnotes
- F1, F3, F5
SPRY
transaction
Common Stock
Sale
- Transaction value
- $534,461
- Shares
- -36,216
- Change %
- -2.3%
- Price
- $14.76
- Shares after
- 1,512,283
- Date
- 20 Aug 2024
- Ownership
- By Lowenthal-Tanimoto Family Trust U/A DTD 4/3/2006
- Footnotes
- F1, F6, F7
SPRY
transaction
Common Stock
Sale
- Transaction value
- $180,028
- Shares
- -11,523
- Change %
- -0.76%
- Price
- $15.62
- Shares after
- 1,500,760
- Date
- 20 Aug 2024
- Ownership
- By Lowenthal-Tanimoto Family Trust U/A DTD 4/3/2006
- Footnotes
- F1, F7, F8
SPRY
transaction
Common Stock
Sale
- Transaction value
- $36,748
- Shares
- -2,261
- Change %
- -0.15%
- Price
- $16.25
- Shares after
- 1,498,499
- Date
- 20 Aug 2024
- Ownership
- By Lowenthal-Tanimoto Family Trust U/A DTD 4/3/2006
- Footnotes
- F1, F7, F9
SPRY
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 4,315,313
- Date
- 20 Aug 2024
- Ownership
- Direct
SPRY
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 1,446,494
- Date
- 20 Aug 2024
- Ownership
- By Richard Lowenthal Charitable Remainder UniTrust Dated January 7, 2020
- Footnotes
- F10
SPRY
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 3,407,847
- Date
- 20 Aug 2024
- Ownership
- By Spouse
* indicates a reported price that failed the local validity check.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses:
| Id | Content |
|---|---|
| F1 | The shares were sold pursuant to a Rule 10b5-1 trading plan entered into on March 31, 2023. |
| F2 | The weighted average sale price for the transaction report was $14.7565 and the range of prices were between $14.09 and $15.09. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares old at each separate price will be provided. |
| F3 | The Reporting Person's spouse is trustee of the trust. The Reporting Person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. |
| F4 | The weighted average sale price for the transaction report was $15.6129 and the range of prices were between $15.10 and $16.09. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares old at each separate price will be provided. |
| F5 | The weighted average sale price for the transaction report was $16.2589 and the range of prices were between $16.15 and $16.36. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares old at each separate price will be provided. |
| F6 | The weighted average sale price for the transaction report was $14.7576,and the range of prices were between $14.09 and $15.09. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares old at each separate price will be provided. |
| F7 | The shares are held in trust for the benefit of the Reporting Person and his spouse. The Reporting Person and his spouse are trustees of the trust. |
| F8 | The weighted average sale price for the transaction report was $15.6234,and the range of prices were between $15.10 and $16.09. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares old at each separate price will be provided. |
| F9 | The weighted average sale price for the transaction report was $16.2532 and the range of prices were between $16.12 and $16.34. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares old at each separate price will be provided. |
| F10 | The Reporting Person is trustee of the trust. |